Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 23.08.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.08.Modus Therapeutics Holding AB: Modus Therapeutics publishes interim report for the second quarter 202411STOCKHOLM, SWEDEN - 23 August 2024: Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes an interim report for the second quarter 2024. The report is available as an attached document...
► Artikel lesen
23.08.Safello Group AB: Safello publishes Interim Report for the Second Quarter 2024, a quarter with Increased Turnover and Framework Agreement with the Swedish Economic Crime Authority10Stockholm, 23 August 2024 | Today, Safello Group AB ("Safello") publishes the company's interim report for the second quarter (1 April-30 June) 2024. The report is attached hereto and can be found on...
► Artikel lesen
23.08.Kancera AB: Interim Report Second Quarter 2024, April 1 - June 3031The period in brief - financial summary for the second quarter 2024Net sales amounted to SEK 0 million (SEK 0 million).R&D expenses amounted to SEK 9,7 million (SEK 16,5 million).Operating loss for...
► Artikel lesen
23.08.Klimator AB: Klimator AB (publ) - Interim report 2, 202425Klimator improves the result with 3 MSEK for second quater and 9 MSEK for the first half year. Second quarter, April 1 - June 30, 2024GroupOperating revenue amounted to SEK 6,174K SEK (SEK 5,331K).Operating...
► Artikel lesen
23.08.Combigene AB: Interim report January - June 2024 for CombiGene AB (publ)22April - June 2024Net sales: TSEK 0 (1,788).Other operating revenues: TSEK 416 (1,413).Profit from financial items: TSEK -7,567 (-6,286).Earnings per share: SEK -0.38 (-0.32).January - June 2024Net sales:...
► Artikel lesen
23.08.Digital Workforce Services Oyj: Digital Workforce Services Plc: Half Year Financial report, January 1 - June 30, 2024: Revenue grew and profitability improved, new sales accelerated growth in Continuous ...3723.8.2024 09:00:01 EEST | Digital Workforce Services Oyj | Company Announcement Digital Workforce Services Plc Company announcement 23 August 2024 at 9.00 EEST Half Year Financial report, January...
► Artikel lesen
23.08.Avtech Sweden AB: AVTECH Sweden AB (publ) Interim Report January - June 202440FINANCIAL KEY FIGURES FOR THE PERIOD 202420242023MSEKQuarter 2Quarter 1Quarter 2Net sales8.67.96.6Operating earnings before depreciation+4.0+4.1+3.2Net earnings+2.7+3.0+2.1Net earnings per share, SEK+0.048+0.053+0.037Cashflow-5.3+3.2+2.6Cash...
► Artikel lesen
23.08.Goodbye Kansas Group AB: Goodbye Kansas Group Interim Report Apr-Jun 202448Second quarter, 1 April - 30 June 2024Net sales decreased by 66 percent to SEK 27.0 million (80.3) primarily due to insufficient sales of new projects during the first half of the year of both game...
► Artikel lesen
23.08.Toleranzia AB: Toleranzia AB: Interim report second quarter 202451Three months, April 1 - June 30Operating profit/loss amounted to KSEK -1 788 (-2 490)Cash flow from operating activities amounted to KSEK -40 (-1 238)Investments in intangible assets amounted to KSEK...
► Artikel lesen
23.08.Cell Impact AB: Cell Impact Q2 2024: New customers and growing sales48The quarter was dominated by continued efforts related to new and established customer projects which led to increased sales. The Group's net sales for the second quarter of 2024 amounted to SEK 23.8...
► Artikel lesen
23.08.Impact Coatings AB: Impact Coatings AB (publ), Interim Report April-June 202462FINANCIAL RESULTS SECOND QUARTER 2024Net sales amounted to SEK 31.7 million (25.1)Net sales, excluding metals for electrolysis, amounted to SEK 31.7 million (22.7) [1]Total revenue amounted to SEK 24.7...
► Artikel lesen
23.08.SaltX Technology Holding AB: SaltX Technology Holding AB Interim Report Q2 - 202475SaltX Technology is a Swedish Greentech company that develops and markets sustainable technology that benefits customers, the climate, and society. Today, the company issued its Interim Report Q2 -...
► Artikel lesen
23.08.Crunchfish AB: Crunchfish publishes half-year report for 202457Today, Crunchfish AB ("Crunchfish") publishes the company's half-year report for the second quarter and the first six months of 2024. Below is a brief summary of the report. Group Financials 2024-04-01 2024-06-30 2023-04-01 2023-06-30 2024-01-01 2024-06-30 2023-01-01 2023-06-30 Net...
► Artikel lesen
23.08.Northgold AB: Northgold AB releases Half-Year Report for April-June 202485Stockholm, 23 August 2024. Northgold AB (Nasdaq First North Growth Market: "NG", "Northgold" or the "Company") today published its Half-Year Report for 2024. Financial highlights of second quarter 2024...
► Artikel lesen
23.08.IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q364FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing...
► Artikel lesen
23.08.Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q238BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), ("Entero Therapeutics" or the "Company"), a clinical-stage biopharmaceutical company specializing in...
► Artikel lesen
23.08.Cellectar Biosciences: Cellectar to Restate Previously Issued Financial Statements - Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq148FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization...
► Artikel lesen
23.08.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing113FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the "Company"), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies...
► Artikel lesen
23.08.Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)279BRISBANE, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics...
► Artikel lesen
23.08.Draganfly Inc: Draganfly Announces Effective Date of Share Consolidation436Vancouver, BC., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems...
► Artikel lesen
Seite:  Weiter >>